The largest database of trusted experimental protocols

Zstk474

Manufactured by Merck Group

ZSTK474 is a laboratory reagent produced by Merck Group. It is a synthetic chemical compound used for research purposes. The core function of ZSTK474 is to inhibit the activity of the phosphoinositide 3-kinase (PI3K) enzyme, which is involved in various cellular processes. ZSTK474 is commonly used in scientific research to study the role of PI3K signaling in different biological systems.

Automatically generated - may contain errors

2 protocols using zstk474

1

Modulating T Cell Activation Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells isolated from spleen and LN using CD4 microbeads
(Miltenyi). 1×106 T cells cultured with platebound
α-CD3 (2C11) and α-CD28 (37.51) from BioXcell at 1μg/mL
each for 48 or 66 hrs. Inhibitors purchased and used as follows: ZSTK474
(1μM, Sigma), Rapamycin (10nM, Selleckchem), NFAT inhibitor (10μM,
Tocoris), Mek inhibitor PD0325901 (100nM, Peprotech) and Erk inhibitor FR180204
(10μM, Tocoris). In vitro TR suppression
assays were performed as previous described (20 (link)). Chemotaxis assay performed as previously described (21 (link)).
+ Open protocol
+ Expand
2

Activation and Polarization of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were activated and cultured in RPMI-1640 medium containing 10% FCS, 50 U/ml Penicillin, 50 µg/ml Streptomycin, 50 µg/ml Gentamycin, 1 nM Sodium Pyruvate, 10 µM Hepes, 2 mM L-glutamine, and 50 µM 2-Mercaptoethanol (complete RPMI). Purified naive T cells were stimulated in 24-well plates (3–5 × 106 cells/well) precoated with the indicated concentrations of anti-CD3 (2C11; Bio-XCell) and anti-CD28 (37.51; Bio-XCell) in PBS in complete medium containing 50–100 U/ml recombinant murine IL-2 (eBioscience) for the indicated times. In some experiments, the class I PI3K inhibitor ZSTK474 (Sigma) was added as indicated. For restimulation experiments, cells were stimulated for 2 d with 1 µg/ml plate-bound anti-CD3/anti-CD28 + IL-2, then removed from stimulus and placed in complete media (without IL-2) overnight before restimulation with plate-bound anti-CD3 as indicated. For polarization of CD4+ T cells into TH1 and TH2 cells, total CD4+ T cells were activated with plate-bound anti-CD3 and anti-CD28 in media containing 200 U/ml IL-2 supplemented with 10 ng/ml IL-12 (eBioscience) and 20 µg/ml anti–IL-4 (11B11; Bio-XCell) for TH1 polarization or 100 ng/ml IL-4 (eBioscience) and 40 µg/ml anti–IFN-γ (XMG1.2; Bio-XCell) for TH2 polarization.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!